A New Method for Estimating the Moisture Content and Flexibility of Polymerised Bentonite Clay Mat

This paper presents a scientific development to address the current absence of a convenient technique to identify the ductile to brittle transition of bentonite clay mats. The instrumented indentation and 3-point bending tests were performed on different liquid polymer hydrated bentonite clay mats at varying moisture content. Properties measured include modified Brinell Hardness Number (BHN) and elastic structural stiffness (EI). The dependence of flexural stiffness on moisture content is demonstrated to conform to a best power function variation. The ductile to brittle transition of clay mat is affected primarily by the change in the moisture content and for the clay mat to remain flexible, critical moisture content of 1.7 times of its plastic limit is required. Results also indicate that a strong correlation between indentation hardness and the structural stiffness. The subsequent outcome in the development of a portable quality control device to monitor the acceptable moisture content level to ensure flexibility of the clay mats was also described in this paper.

Dual stimulation of antigen presenting cells using carbon nanotube-based vaccine delivery system for cancer immunotherapy

Although anti−cancer immuno−based combinatorial therapeutic approaches have shown promising results, efficient tumour eradication demands further intensification of anti−tumour immune response. With the emerging field of nanovaccinology, multi−walled carbon nanotubes (MWNTs) have manifested prominent potentials as tumour antigen nanocarriers. Nevertheless, the utilization of MWNTs in co−delivering antigen along with different types of immunoadjuvants to antigen presenting cells (APCs) has not been investigated yet. We hypothesized that harnessing MWNT for concurrent delivery of cytosine−phosphate−guanine oligodeoxynucleotide (CpG) and anti-CD40 Ig (αCD40), as immunoadjuvants, along with the model antigen ovalbumin (OVA) could potentiate immune response induced against OVA−expressing tumour cells. We initially investigated the effective method to co−deliver OVA and CpG using MWNT to the APC. Covalent conjugation of OVA and CpG prior to loading onto MWNTs markedly augmented the CpG−mediated adjuvanticity, as demonstrated by the significantly increased OVA−specific T cell responses in vitro and in C57BL/6 mice. αCD40 was then included as a second immunoadjuvant to further intensify the immune response. Immune response elicited in vitro and in vivo by OVA, CpG and αCD40 was significantly potentiated by their co−incorporation onto the MWNTs. Furthermore, MWNT remarkably improved the ability of co−loaded OVA, CpG and αCD40 in inhibiting the growth of OVA−expressing B16F10 melanoma cells in subcutaneous or lung pseudo−metastatic tumour models. Therefore, this study suggests that the utilization of MWNTs for the co−delivery of tumour−derived antigen, CpG and αCD40 could be a competent approach for efficient tumours eradication.